A checklist is presented to assist with the evaluation of a controlled
trial in migraine prophylaxis. The following points are discussed bri
efly: aim of the study, design of the study, efficacy parameters, and
presentation of results and statistics. Choice among drugs for migrain
e prophylaxis is described taking into account: clinical efficacy, sci
entific proof for efficacy, and contraindications.